Physician profile
Jill E Hess
NPI 1063471407
$1,559.83
in general payments reported to CMS, 2019-2025
16 companies · $24.19 in 2025
The $24.19 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $335 · 2023: $523 · 2024: $296 · 2025: $24.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.28 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $450.89 | 2021-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $194.46 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $178.68 | 2023-2024 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $165.86 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $110.86 | 2021-2022 | |
| Teleflex LLC | $108.93 | 2021-2023 | Urolift |
| Axonics, INC. | $59.96 | 2021-2023 | Axonics |
| Lilly USA, LLC | $56.53 | 2024 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $46.45 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $42.90 | 2024 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $41.33 | 2024 | Airsupra |
| Eisai INC. | $27.97 | 2024 | |
| Cequr Corporation | $22.06 | 2024 | Cequr Simplicity |
| Allergan, INC. | $21.25 | 2021 | |
| Novo Nordisk INC | $17.75 | 2024 | Ozempic, Rybelsus |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.95 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.